Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Applying to Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center · Houston, Texas
Answer a few short questions to share with the research team.